A metal-organic silicon composite nano antibacterial agent and its preparation method and application
Zinc-silicon nano-microspheres were prepared by 60Coγ-ray irradiation method and loaded with silver nanoparticles to form metal-silicon composite nano-anti-bacterial microspheres, which solved the problems of antibacterial agent loss and drug resistance, and realized the grammar bacteria The high-efficiency antibacterial effect and has potential applications in the fields of medicine and cultural relics protection.
Patent Information
- Application Number
- CN202211555408.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-12-06
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2042-12-06
AI Technical Summary
The existing antibacterial agents have problems with easy loss of antibacterial agents and drug resistance in the fields of medicine, health and cultural relics protection, and the high surfactivity of nanosilver leads to poor dispersion and degradation of antibacterial properties.
Zinc-silicon nano-microspheres were prepared as carrier by 60Coγ-ray irradiation method, and silver nanoparticles were loaded in situ by chemical reduction to form metal-silicon composite nano-anti-bacterial microspheres to improve the antibacterial effect.
The prepared metal-organosilicon composite nanoantibiotic microspheres have excellent antibacterial effects on both Gram-positive and negative bacteria, with significantly higher antibacterial rates and bactericidal rates than AgNO3, and can be well dispersed in wound dressings or coatings.
Smart Images

Figure HDA0003983118880000011 
Figure HDA0003983118880000012 
Figure HDA0003983118880000013
Abstract
Description
Technical Field
[0001] The invention relates to the field of antibacterial materials, and in particular to a metal-organic silicon composite nano antibacterial agent and a preparation method and application thereof. Background Art
[0002] Bacteria are common microorganisms in the natural environment and are widely present in soil, air, water and other areas of human life. Many of these bacteria have harmful effects on human health and all aspects of production and life (HonigsbaumM.The Lancet.2018,391,420). In the field of medicine and health, antibiotics such as penicillin and streptomycin are commonly used antibacterial agents, but due to the abuse of antibiotics, some pathogenic bacteria gradually develop resistance to various antibiotics, resulting in a continuous increase in the number of deaths due to bacterial infections and the emergence of "super bacteria". Therefore, bacterial resistance is considered to be one of the most serious global public threats of this century (Catalano A, Iacopetta D, Ceramella J, et al. Molecules.2022,27,616). In addition to organisms, bacteria can also cause irreparable damage to objects. For example, during the preservation of stone or paper cultural relics, bacteria attached to the surface or inside will produce organic acids, heteropolysaccharides and other substances during their growth. These substances can cause varying degrees of damage to cultural relics through acid corrosion, plaque coverage, oxidation and discoloration, etc., which is the phenomenon of biological degradation, posing a severe challenge to cultural relic protection (Gaylarde C, Little B. Science of The Total Environment. 2022, 823, 159193). Traditional antibiotics and small molecule organic antimicrobial agents (such as ethanol) are difficult to use in certain fields such as cultural relic protection due to problems such as easy loss and drug resistance. Therefore, the development of non-antibiotic antimicrobial agents is crucial to solving the problems of easy loss and drug resistance of traditional antimicrobial agents.
[0003] Humans have long discovered that heavy metal ions and their compounds have excellent broad-spectrum antibacterial effects. Studies have shown that heavy metal ions (such as Zn 2+ , Ag +etc.) can complex with functional groups on proteins in bacteria, causing the proteins to lose activity. They can also bind to the bases of DNA, destroy the structure of DNA, thereby affecting the normal metabolic process of cells, hindering bacterial reproduction and even causing cell apoptosis (Zheng KY, Setyawati MI, Letong DT, et al. Coordination Chemistry Reviews. 2018, 357, 1). Not only that, the presence of heavy metal ions can also cause oxidative stress in cells, produce reactive oxygen species (ROS), and kill bacteria (Liao SJ, Zhang YP, et al. International Journal of Nanomedicine. 2019, 14 1469). These antibacterial mechanisms of heavy metal ions are different from those of antibiotics. They will not make bacteria resistant, and thus can achieve long-term and effective antibacterial effects. Among the antibacterial metal ions studied, the antibacterial effect of silver ions is particularly significant (Demiric S, Ustaoglu Z, et al. Applied Biochemistry and Biotechnology. 2014, 172, 1652). However, silver ions are easily soluble in water or react with organic matter in the environment. Therefore, when used alone in the form of silver ions, they are easily lost and have low antibacterial efficiency.
[0004] Nanosilver is a silver single substance particle with a particle size below 100nm. It has surface effects, quantum size effects, etc. It can directly enter the bacteria, effectively and continuously release silver ions in the bacteria through oxidation by oxygen molecules and water dissolution, destroying the respiratory enzymes and DNA of bacteria, etc., thereby showing efficient antibacterial effects (Hahn A, Brandes G, et al. Journal of Controlled Release. 2011, 154, 164). Therefore, in recent years, the application of nanosilver in the field of biological antibacterial has become more and more common. However, silver nanoparticles have high surface activity and are easy to agglomerate, resulting in poor dispersibility in the medium and decreased antibacterial properties. Surface modification of nanosilver or loading it onto a suitable carrier can effectively avoid the agglomeration of silver nanoparticles. However, if nanosilver is directly surface modified, the ligands on the surface of nanosilver often block the contact between nanosilver and oxygen molecules, thereby slowing down the Ag +The release rate and the generation rate of ROS lead to a decrease in antibacterial properties (Xue P, Shan YX, et al. New Journal of Chemistry. 2019, 43, 2870). Therefore, in theory, loading nanosilver can avoid the agglomeration of nanosilver without weakening the antibacterial effect of nanosilver, and retain as many active surfaces as possible. However, in actual preparation, the requirements for the carrier are relatively high. In addition to being able to efficiently fix nanosilver, there are many other requirements, otherwise it is easy to affect the antibacterial effect of the product. Therefore, how to obtain an antibacterial agent that can truly bring excellent antibacterial effects faces greater technical challenges. Summary of the invention
[0005] In view of this, the present invention provides a metal-organic silicon composite nano antibacterial agent and its preparation method and application. The metal-organic silicon composite nano antibacterial agent prepared by the present invention has excellent antibacterial effect on both Gram-positive bacteria and Gram-negative bacteria, and the preparation method is simple, energy-saving and environmentally friendly.
[0006] The present invention provides a method for preparing a metal-organic silicon composite nano antibacterial agent, comprising the following steps:
[0007] a) mixing zinc nitrate hexahydrate, 3-aminopropyltriethoxysilane and water to obtain a mixed solution;
[0008] b) Under a protective atmosphere, the mixed solution is subjected to 60 Coγ-ray irradiation, then solid-liquid separation and washing, the obtained solid product is dispersed in water to obtain a zinc-organosilicon nanoparticle dispersion;
[0009] c) mixing the zinc-organosilicon nanosphere dispersion with an AgNO3 aqueous solution, then performing solid-liquid separation and washing, and dispersing the obtained solid product in water to obtain a dispersion;
[0010] d) mixing the dispersion obtained in step c) with a reducing agent solution for reaction, and then performing solid-liquid separation, washing and drying to obtain a metal-organosilicon composite nano antibacterial agent.
[0011] Preferably, in step a), the molar ratio of zinc nitrate hexahydrate to 3-aminopropyltriethoxysilane is 1:(9-15).
[0012] Preferably, in step b), the irradiation conditions are: dose rate 9-76 Gy / min, irradiation time 2-24 h, total absorbed dose 1-110 kGy.
[0013] Preferably, the molar ratio of AgNO3 in the AgNO3 aqueous solution in step c) to 3-aminopropyltriethoxysilane in step a) is (0.05-0.5):1.
[0014] Preferably, in step d), the reducing agent solution is a NaBH4 aqueous solution.
[0015] Preferably, in step d), the molar ratio of the reducing agent in the reducing agent solution to the AgNO3 in the AgNO3 aqueous solution in step c) is (2-5):1.
[0016] Preferably, in step a), the volume ratio of 3-aminopropyltriethoxysilane to water is 1:(25-50).
[0017] Preferably, in step d), the drying is freeze-drying.
[0018] The present invention also provides a metal-organic silicon composite nano antibacterial agent prepared by the preparation method described in the above technical scheme.
[0019] The present invention also provides an application of the metal-organic silicon composite nano antibacterial agent described in the above technical solution as an antibacterial agent for Gram-positive bacteria and / or Gram-negative bacteria.
[0020] The preparation method provided by the present invention utilizes 60 Coγ-rays are used to irradiate an aqueous solution containing APTES and zinc nitrate in a specific composition ratio to obtain zinc / organosilicon composite nano-microspheres with a particle size of 50 to 200 nm. Using the zinc / organosilicon composite nano-microspheres as carriers, silver nano-particles with a size of 6 to 15 nm are in situ loaded by a chemical reduction method, thereby obtaining a highly efficient metal-organosilicon composite nano-antibacterial microsphere. The metal-organosilicon composite nano-antibacterial microspheres prepared by the present invention have excellent antibacterial effects on both Gram-positive bacteria and Gram-negative bacteria. The prepared antibacterial microspheres can also be well dispersed in wound dressings or coatings, and therefore have potential applications in the fields of medical antibacterial, cultural relics protection, etc.
[0021] The experimental results show that the antibacterial rate of the composite nano-microspheres (Zn / oSiNP@Ag) provided by the present invention against Pseudomonas aeruginosa is more than 1.8 times that of AgNO3, and the bactericidal rate against Pseudomonas aeruginosa is more than 1.5 times that of AgNO3; the antibacterial rate of the composite nano-microspheres (Zn / oSiNP@Ag) against Bacillus subtilis is more than 1.03 times that of AgNO3, and the bactericidal rate against Bacillus subtilis is more than 1.5 times that of AgNO3. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on the provided drawings without paying creative work.
[0023] Figure 1 TEM image of the zinc-organic silicon nanosphere carrier (Zn / oSiNP) in Example 1;
[0024] Figure 2 This is the infrared spectrum of the zinc-organic silicon nanoparticle carrier (Zn / oSiNP) in Example 1;
[0025] Figure 3 is the X-ray photoelectron spectrum of the zinc-organic silicon nanosphere carrier (Zn / oSiNP) in Example 1;
[0026] Figure 4 TEM image of the zinc-organic silicon nanocomposite nanospheres (Zn / oSiNP@Ag) loaded with silver nanoparticles obtained in Example 1;
[0027] Figure 5 The XRD pattern of the zinc-organic silicon nanocomposite nanospheres (Zn / oSiNP@Ag) loaded with silver nanoparticles obtained in Example 1;
[0028] Figure 6 The figure is a test result of the antibacterial activity of the organosilicon carrier (Zn / oSiNP), composite nanoparticles (Zn / oSiNP@Ag) and solid SiO2 microparticles against Pseudomonas aeruginosa in Example 1;
[0029] Figure 7 The figure is a test diagram of the antibacterial effect of each reagent in Example 1 on Pseudomonas aeruginosa at different mass concentrations; wherein, Figure 7 (a) is the antibacterial effect test diagram of different mass concentrations of organic silicon carrier (Zn / oSiNP), Figure 7 (b) is the antibacterial effect test diagram of composite nanoparticles (Zn / oSiNP@Ag) with different mass concentrations. Figure 7 (c) is a test diagram of the antibacterial effect of AgNO3 aqueous solutions with different mass concentrations;
[0030] Figure 8 The graph is a test chart of bacterial growth of Pseudomonas aeruginosa cultured on agar plates for 24 hours with different mass concentrations of composite nanoparticles (Zn / oSiNP@Ag); Figure 8a~8f are the effect diagrams at 0μg / mL, 100μg / mL, 200μg / mL, 300μg / mL, 400μg / mL, and 600μg / mL, respectively;
[0031] Fig. 9 The graph is a test chart of bacterial growth of Pseudomonas aeruginosa cultured on agar plates for 24 hours with different mass concentrations of AgNO3; Fig. 9 a~9f are the effect diagrams at 0μg / mL, 6μg / mL, 10μg / mL, 15μg / mL, 20μg / mL, and 25μg / mL, respectively;
[0032] Fig.10 This is a test result diagram of the antibacterial activity of the organosilicon carrier (Zn / oSiNP), composite nanoparticles (Zn / oSiNP@Ag) and solid SiO2 microparticles against Bacillus subtilis in Example 1;
[0033] Fig.11 The figure is a test diagram of the antibacterial effect of each reagent in Example 1 on Bacillus subtilis at different mass concentrations; wherein, Fig.11 (a) is the antibacterial effect test diagram of organic silicon carrier (Zn / oSiNP) with different mass concentrations. Fig.11 (b) is the antibacterial effect test diagram of composite nanoparticles (Zn / oSiNP@Ag) with different mass concentrations. Fig.11 (c) is a test diagram of the antibacterial effect of AgNO3 aqueous solutions with different mass concentrations;
[0034] Fig.12 The graph is a test chart of bacterial growth of Bacillus subtilis cultured with different mass concentrations of composite nanoparticles (Zn / oSiNP@Ag) on agar plates for 24 hours; Fig.12 a~12d are the effect diagrams at 0μg / mL, 300μg / mL, 400μg / mL, and 600μg / mL respectively;
[0035] Fig.13 The figure is a test chart of bacterial growth of Bacillus subtilis culture solution with different mass concentrations of AgNO3 cultured on agar plate for 24 hours; Fig.13 a to 13e are the effect diagrams at concentrations of 0 μg / mL, 10 μg / mL, 15 μg / mL, 20 μg / mL, and 25 μg / mL, respectively;
[0036] Fig.14 TEM image of zinc-organic silicon nanosphere carrier (Zn / oSiNP) in Example 2;
[0037] Fig.15TEM image of the zinc-organic silicon nanocomposite nanospheres (Zn / oSiNP@Ag) loaded with silver nanoparticles obtained in Example 2. DETAILED DESCRIPTION
[0038] The present invention provides a method for preparing a metal-organic silicon composite nano antibacterial agent, comprising the following steps:
[0039] a) mixing zinc nitrate hexahydrate, 3-aminopropyltriethoxysilane and water to obtain a mixed solution;
[0040] b) Under a protective atmosphere, the mixed solution is subjected to 60 Coγ-ray irradiation, then solid-liquid separation and washing, the obtained solid product is dispersed in water to obtain a zinc-organosilicon nanoparticle dispersion;
[0041] c) mixing the zinc-organosilicon nanosphere dispersion with an AgNO3 aqueous solution, then performing solid-liquid separation and washing, and dispersing the obtained solid product in water to obtain a dispersion;
[0042] d) mixing the dispersion obtained in step c) with a reducing agent solution for reaction, and then performing solid-liquid separation, washing and drying to obtain a metal-organosilicon composite nano antibacterial agent.
[0043] The preparation method provided by the present invention utilizes 60 Coγ-rays are used to irradiate an aqueous solution containing APTES and zinc nitrate in a specific composition ratio to obtain zinc / organosilicon composite nano-microspheres with a particle size of 50 to 200 nm. Using the zinc / organosilicon composite nano-microspheres as carriers, silver nano-particles with a size of 6 to 15 nm are in situ loaded by a chemical reduction method, thereby obtaining a highly efficient metal-organosilicon composite nano-antibacterial microsphere. The metal-organosilicon composite nano-antibacterial microspheres prepared by the present invention have excellent antibacterial effects on both Gram-positive bacteria and Gram-negative bacteria. The prepared antibacterial microspheres can also be well dispersed in wound dressings or coatings, and therefore have potential applications in the fields of medical antibacterial, cultural relics protection, etc.
[0044] Regarding step a) :
[0045] a) Zinc nitrate hexahydrate, 3-aminopropyltriethoxysilane and water are mixed to obtain a mixed solution.
[0046] In the present invention, the sources of the zinc nitrate hexahydrate (Zn(NO3)2·6H2O) and 3-aminopropyltriethoxysilane (APTES) are not particularly limited, and they can be commercial products. In the present invention, the molar ratio of the zinc nitrate hexahydrate: 3-aminopropyltriethoxysilane is preferably 1: (9-15), specifically 1: 9, 1: 10, 1: 11, 1: 12, 1: 13, 1: 14, 1: 15.
[0047] In the present invention, the water is preferably deionized water. In the present invention, the volume ratio of 3-aminopropyltriethoxysilane to water is preferably 1:(25-50), specifically 1:25, 1:30, 1:35, 1:40, 1:45, 1:50.
[0048] In the present invention, the method of mixing zinc nitrate hexahydrate, 3-aminopropyltriethoxysilane and water is preferably: a1) dissolving zinc nitrate hexahydrate in water to obtain a solution; a2) adding 3-aminopropyltriethoxysilane dropwise to the solution and mixing evenly to obtain a mixed solution. Specifically, in step a1), zinc nitrate hexahydrate and water are mixed and stirred until completely dissolved to obtain a solution. In step a2), 3-aminopropyltriethoxysilane is added dropwise to the solution, and stirred under magnetic stirring conditions until the mixed solution becomes clear and transparent, thereby obtaining a uniform mixed solution.
[0049] Regarding step b) :
[0050] b) Under a protective atmosphere, the mixed solution is subjected to 60 Coγ-ray irradiation, then solid-liquid separation and washing are performed, and the obtained solid product is dispersed in water to obtain a zinc-organosilicon nano-microsphere dispersion.
[0051] In the present invention, in step b), a protective atmosphere is first formed. Specifically, it can be achieved by placing the mixed solution obtained in step a) in a sample bottle, then introducing a protective gas and sealing the sample bottle. The present invention has no particular limitation on the type of protective gas providing the protective atmosphere, and it can be any conventional protective gas known to those skilled in the art, such as nitrogen or argon.
[0052] In the present invention, under a protective atmosphere, the mixed solution is subjected to 60 Coγ-ray irradiation, specifically, placing a sample bottle containing the mixed solution into a cobalt source chamber, 60The irradiation is carried out in a Coγ-ray radiation field. In the present invention, the irradiation conditions are preferably: a dose rate of 9 to 76 Gy / min, an irradiation time of 2 to 24 hours, and a total absorbed dose of 1 to 110 kGy. Wherein, the dose rate can specifically be 9 Gy / min, 10 Gy / min, 15 Gy / min, 20 Gy / min, 25 Gy / min, 30 Gy / min, 35 Gy / min, 40 Gy / min, 45 Gy / min, 50 Gy / min, 55 Gy / min, 60 Gy / min, 65 Gy / min, 70 Gy / min, 75 Gy / min, 76 Gy / min. The irradiation time can specifically be 2 hours, 4 hours, 8 hours, 10 hours, 12 hours, 14 hours, 16 hours, 18 hours, 20 hours, 22 hours, 24 hours. The total absorbed dose can be specifically 1 kGy, 5 kGy, 10 kGy, 15 kGy, 20 kGy, 25 kGy, 30 kGy, 35 kGy, 40 kGy, 45 kGy, 50 kGy, 55 kGy, 60 kGy, 65 kGy, 70 kGy, 75 kGy, 80 kGy, 85 kGy, 90 kGy, 95 kGy, 100 kGy, 105 kGy, 110 kGy. In the present invention, the temperature conditions of the irradiation treatment are not particularly limited, and can be carried out at room temperature, which can be 10 to 35 ° C, specifically 10 ° C, 15 ° C, 20 ° C, 25 ° C, 30 ° C, 35 ° C. During the irradiation treatment, high-energy rays promote the hydrolysis and condensation reaction of 3-aminopropyltriethoxysilane complexed with zinc ions through the interaction with water or 3-aminopropyltriethoxysilane molecules, thereby forming zinc-organic silicon composite nanospheres (denoted as Zn / oSiNPs) in the system.
[0053] In the present invention, after irradiation treatment, a mixed solution containing zinc-organosilicon nano-microspheres is obtained, and the present invention performs solid-liquid separation and washing treatment on it. Among them, the solid-liquid separation method is preferably centrifugal treatment. The speed of the centrifugal treatment is preferably 8 to 12 krpm, specifically 8 krpm, 9 krpm, 10 krpm, 11 krpm, 12 krpm; the time of the centrifugal treatment is preferably 5 to 10 min, specifically 5 min, 6 min, 7 min, 8 min, 9 min, 10 min. The washing is preferably water washing. After the above treatment, a zinc-organosilicon composite nano-microsphere solid product is obtained. In the present invention, the particle size of the zinc-organosilicon nano-microspheres is 50 to 200 nm.
[0054] In the present invention, after the above treatment, the obtained solid product is dispersed in water to obtain a zinc-organosilicon nanosphere dispersion. Wherein, the water is preferably deionized water. The volume ratio of 3-aminopropyltriethoxysilane in step a) to water in step b) is preferably 1: (25-50), specifically 1: 25, 1: 30, 1: 35, 1: 40, 1: 45, 1: 50. After the above treatment, a zinc-organosilicon nanosphere dispersion is obtained.
[0055] In the prior art, the methods for preparing organosilicon nano-microspheres basically require high temperatures or the addition of emulsifiers, and usually require multi-step reactions, which increases costs and the subsequent treatment of impurities such as emulsifiers. The present invention, however, synthesizes zinc-organosilicon nano-microspheres by the above-mentioned irradiation method, which can be carried out at room temperature, does not require emulsifiers, and can be prepared by a one-step irradiation reaction. Furthermore, the obtained nano-microspheres have suitable size, stability, skeleton structure, etc., and can achieve good compatibility with silver in subsequent preparation, thereby facilitating the improvement of antibacterial effect.
[0056] Regarding step c) :
[0057] c) mixing the zinc-organosilicon nanosphere dispersion with an AgNO3 aqueous solution, then performing solid-liquid separation and washing, and dispersing the obtained solid product in water to obtain a dispersion.
[0058] In the present invention, the concentration of the AgNO3 aqueous solution is preferably 0.01-0.08 mol / L, specifically 0.01 mol / L, 0.02 mol / L, 0.03 mol / L, 0.04 mol / L, 0.05 mol / L, 0.06 mol / L, 0.07 mol / L, 0.08 mol / L. In the present invention, the molar ratio of AgNO3 in the AgNO3 aqueous solution to 3-aminopropyltriethoxysilane in step a) is preferably (0.05-0.5):1, specifically 0.05:1, 0.10:1, 0.15:1, 0.20:1, 0.25:1, 0.30:1, 0.35:1, 0.40:1, 0.45:1, 0.50:1.
[0059] In the present invention, the method of mixing the zinc-organosilicon nanosphere dispersion with the AgNO3 aqueous solution is preferably: dropwise adding the AgNO3 aqueous solution to the zinc-organosilicon nanosphere dispersion, and stirring and mixing under light-proof conditions. Wherein, the stirring rate is preferably 200-500rpm, specifically 200rpm, 250rpm, 300rpm, 350rpm, 400rpm, 450rpm, 500rpm. The stirring time is preferably 4-12h, specifically 4h, 6h, 8h, 10h, 12h. In the above mixing process, silver ions are fully adsorbed onto the zinc-organosilicon nanosphere carrier.
[0060] In the present invention, after the above-mentioned mixing treatment, solid-liquid separation and washing are carried out. Wherein, the solid-liquid separation method is preferably centrifugal treatment. The washing is preferably water washing, and the non-adsorbed silver ions are removed by water washing. After the above treatment, a zinc-organosilicon nano-microsphere solid product adsorbing silver ions is obtained.
[0061] In the present invention, after the above treatment, the obtained solid product is dispersed in water to obtain a dispersion. Wherein, the water is preferably deionized water. The volume ratio of 3-aminopropyltriethoxysilane in step a) to water in step c) is preferably 1: (50-75), specifically 1: 50, 1: 55, 1: 60, 1: 65, 1: 70, 1: 75.
[0062] Regarding step d) :
[0063] d) mixing the dispersion obtained in step c) with a reducing agent solution for reaction, and then performing solid-liquid separation, washing and drying to obtain a metal-organosilicon composite nano antibacterial agent.
[0064] In the present invention, the reducing agent solution is an aqueous solution of the reducing agent. Wherein, the reducing agent is preferably NaBH4, that is, the reducing agent solution is an aqueous solution of NaBH4. In the present invention, the concentration of the reducing agent solution is preferably 0.04-0.2 mol / L, specifically 0.04 mol / L, 0.08 mol / L, 0.12 mol / L, 0.16 mol / L, 0.2 mol / L. In the present invention, the molar ratio of the reducing agent in the reducing agent solution: the AgNO3 in the AgNO3 aqueous solution in step c) is preferably (2-5):1, specifically 2:1, 3:1, 4:1, 5:1.
[0065] In the present invention, the dispersion obtained in step c) is preferably mixed with the reducing agent solution by adding the reducing agent solution dropwise to the dispersion obtained in step c). The temperature of the mixing and reaction is preferably -2 to 4°C, and can be specifically carried out in an ice-water bath. In the present invention, the time for continuing the reaction after the dropwise addition is preferably 15 to 40 minutes, specifically 15 minutes, 20 minutes, 25 minutes, 30 minutes, 35 minutes, and 40 minutes. In the above reaction process, the silver ions adsorbed on the zinc-organosilicon nanospheres are reduced to silver nanoparticles, so that the silver nanoparticles are successfully loaded onto the zinc-organosilicon nanospheres.
[0066] In the present invention, after the above reaction, a reaction solution containing the above composite nano-microspheres is obtained, and the present invention performs solid-liquid separation, washing and drying on the reaction solution. Wherein, the solid-liquid separation method is preferably centrifugal treatment. The washing is preferably water washing, and the excess reducing agent is removed by water washing. The drying is preferably freeze drying. After the above treatment, zinc-organosilicon nano-composite nano-microspheres loaded with silver nanoparticles (denoted as Zn / oSiNP@Ag), i.e., metal-organosilicon composite nano-antibacterial agent, are obtained, wherein the particle size of the overall composite microspheres is 50 to 200 nm, and the particle size of the loaded silver nanoparticles is 6 to 15 nm. In some embodiments of the present invention, the particle size of the zinc-organosilicon nano-microsphere carrier is 70 to 120 nm, and the particle size of the loaded silver nanoparticles is 8 to 12 nm.
[0067] The present invention also provides a metal-organic silicon composite nano antibacterial agent prepared by the preparation method described in the above technical scheme.
[0068] The present invention also provides a use of the metal-organic silicon composite nano antibacterial agent described in the above technical solution as an antibacterial agent for Gram-positive bacteria and / or Gram-negative bacteria, wherein the Gram-positive bacteria are such as Bacillus subtilis, and the Gram-negative bacteria are such as Pseudomonas aeruginosa.
[0069] The preparation method provided by the present invention utilizes 60 Coγ-rays are used to irradiate an aqueous solution containing APTES and zinc nitrate in a specific composition ratio to obtain zinc / organosilicon composite nano-microspheres with a particle size of 50 to 200 nm. Using the zinc / organosilicon composite nano-microspheres as carriers, silver nano-particles with a size of 6 to 15 nm are in situ loaded by a chemical reduction method, thereby obtaining a highly efficient metal-organosilicon composite nano-antibacterial microsphere. The metal-organosilicon composite nano-antibacterial microspheres prepared by the present invention have excellent antibacterial effects on both Gram-positive bacteria and Gram-negative bacteria. The prepared antibacterial microspheres can also be well dispersed in wound dressings or coatings, and therefore have potential applications in the fields of medical antibacterial, cultural relics protection, etc.
[0070] The experimental results show that the antibacterial rate of the composite nano-microspheres (Zn / oSiNP@Ag) provided by the present invention against Pseudomonas aeruginosa is more than 1.8 times that of AgNO3, and the bactericidal rate against Pseudomonas aeruginosa is more than 1.5 times that of AgNO3; the antibacterial rate of the composite nano-microspheres (Zn / oSiNP@Ag) against Bacillus subtilis is more than 1.03 times that of AgNO3, and the bactericidal rate against Bacillus subtilis is more than 1.5 times that of AgNO3.
[0071] In order to further understand the present invention, preferred embodiments of the present invention are described below in conjunction with examples. However, it should be understood that these descriptions are only for further illustrating the features and advantages of the present invention, rather than limiting the claims of the present invention.
[0072] Example 1
[0073] 1. Preparation of antimicrobial microspheres
[0074] 1.1. Preparation of Zn / oSiNP microsphere carrier
[0075] a) Weigh 30 mg of zinc nitrate hexahydrate and dissolve it in 10 mL of deionized water, stir until completely dissolved, and obtain a solution. Then, take 200 μL of 3-aminopropyltriethoxysilane (the molar ratio of zinc nitrate hexahydrate to 3-aminopropyltriethoxysilane is preferably 1:9), add it dropwise into the above solution, and stir it magnetically until it becomes clear and transparent to obtain a mixed solution.
[0076] b) Place the above mixed solution in a sample bottle, introduce nitrogen and seal it, then place the sample bottle in the cobalt source chamber and place it in a 60 The irradiation was carried out in a Coγ-ray radiation field under the conditions of a dose rate of 76 Gy / min, an irradiation time of 24 h, and a total absorbed dose of 109.44 kGy. After irradiation, a mixed solution containing zinc-organosilicon nano-microspheres was obtained. Then, centrifugal separation was carried out in a centrifuge (centrifugal speed of 10 krpm, centrifugal time of 5 min), washed twice with deionized water, and dispersed in 10 mL of deionized water to obtain a zinc-organosilicon nano-microsphere dispersion.
[0077] Characterization:
[0078] The morphology of zinc-organic silicon nanoparticles (Zn / oSiNPs) was characterized by transmission electron microscopy (TEM, Hitachi H7650, 100 kV). Figure 1 As shown, Figure 1 TEM image of the zinc-organic silicon nanoparticle carrier (Zn / oSiNP) in Example 1. It can be seen that the obtained microsphere carrier is a spherical particle with a particle size of 70 to 120 nm. The infrared spectrum (FTIR, Bruker TENSORII) of the zinc-organic silicon nanoparticle (Zn / oSiNP) is as follows: Figure 2 As shown, 1008cm -1 The strong and broad absorption peak near it is the Si-O-Si antisymmetric stretching vibration peak, 755cm -1 The absorption peak at 1600 cm is caused by the stretching vibration of Si-C, and the in-plane bending vibration peak of -NH2 is at 1600 cm -1 The X-ray photoelectron spectroscopy (XPS, ESCALAB 250Xi) of zinc-organic silicon nanoparticles (Zn / oSiNP) is shown in Figure 2. Figure 3 As shown, it shows that Zn 2+ It exists in the form of complex with amino group.
[0079] 1.2 Preparation of Zn / oSiNP@Ag microspheres
[0080] c) Adding dropwise an aqueous solution of AgNO3 (concentration 0.04 mol / L, 5 mL in total, i.e., the molar ratio of AgNO3: 3-aminopropyltriethoxysilane in step a) is 0.25:1) to the zinc-organosilicon nanosphere dispersion obtained in step b), stirring the mixture magnetically at 400 rpm for 8 h in a dark environment, centrifuging the mixture, washing the mixture three times with deionized water, and then dispersing the resulting solid product in 15 mL of deionized water to obtain a dispersion.
[0081] d) dropping a NaBH4 aqueous solution (concentration 0.2 mol / L, 5 mL in total, i.e., the molar ratio of NaBH4:AgNO3 in the AgNO3 aqueous solution in step c) is 5:1) into the dispersion, and continuing to react in an ice-water bath for 30 min after the addition is complete. Then, the obtained reaction solution is centrifuged, washed with deionized water and freeze-dried to obtain a brown solid product, i.e., zinc-organic silicon nanocomposite nanospheres (Zn / oSiNP@Ag) loaded with silver nanoparticles.
[0082] Characterization:
[0083] The transmission electron microscopy (TEM, Hitachi H7650, 100 kV) and X-ray diffraction spectra (XRD, SmartLab) of the obtained zinc-organic silicon nanocomposite nanospheres loaded with silver nanoparticles (Zn / oSiNP@Ag) are shown as follows: Figure 4-5 As shown, Figure 4 TEM image of the zinc-organic silicon nanocomposite nanospheres (Zn / oSiNP@Ag) loaded with silver nanoparticles obtained in Example 1. Figure 5The XRD diagram of the zinc-organic silicon nanocomposite nanosphere (Zn / oSiNP@Ag) loaded with silver nanoparticles obtained in Example 1, wherein the XRD spectra of Ag, the zinc-organic silicon nanosphere (Zn / oSiNP) in step b), and the zinc-organic silicon nanocomposite nanosphere (Zn / oSiNP@Ag) loaded with silver nanoparticles obtained in step d) are respectively shown. It can be seen that the silver nanoparticles are successfully loaded on the carrier, and the particle size of the silver nanoparticles is 8 to 12 nm. The results of the inductively coupled plasma emission spectrum (ICP, Optima7300DV) of the Zn / oSiNP@Ag composite nanospheres show that the loading rate L(Ag) of the silver nanoparticles in the composite nanospheres, that is, the percentage of the mass of the silver nanoparticles to the mass of the composite nanosphere carrier, is 1.86%.
[0084] 2. Antibacterial test (Gram-negative bacteria - Pseudomonas aeruginosa)
[0085] 2.1. Antibacterial activity of different reagents
[0086] The organic silicon carrier (Zn / oSiNP), composite nanoparticles (Zn / oSiNP@Ag), solid SiO2 microspheres (by The method used TEOS (self-made, particle size 120nm) and LB medium were mixed evenly, and 500μL of 10 8 CFU / mL of Pseudomonas aeruginosa bacterial solution, so that the initial bacterial solution concentration is 10 6 CFU / mL, and then co-cultured at 30°C for 24 h, and the absorbance (OD 600 ) were used to test the anti-Pseudomonas aeruginosa effects of the three, and a negative control group inoculated with only bacteria (no antimicrobial agent added) and a positive control group without bacteria were set up. Figure 6 , Figure 6 The figure shows the antibacterial test effect of the organosilicon carrier (Zn / oSiNP), composite nanoparticles (Zn / oSiNP@Ag) and solid SiO2 microspheres on Pseudomonas aeruginosa in Example 1. It can be seen that compared with the solid SiO2 microsphere group, the organosilicon carrier (Zn / oSiNP) group has a certain antibacterial property, while the composite nanoparticles (Zn / oSiNP@Ag) have significant antibacterial property, which significantly improves the antibacterial effect.
[0087] 2.2 Comparison of antibacterial rates of different reagents
[0088] Different concentrations of organic silicon carrier (Zn / oSiNP), composite nanoparticles (Zn / oSiNP@Ag), and AgNO3 aqueous solution were mixed with LB medium and 500 μL of 10 8CFU / mL Pseudomonas aeruginosa bacterial solution, so that the initial bacterial solution concentration is 10 6 CFU / mL, then co-cultured at 30°C for 24h, and recorded the OD of the bacterial solution at different times 600 Value, the result is Figure 7 As shown, Figure 7 The figure is a test diagram of the antibacterial effect of each reagent in Example 1 on Pseudomonas aeruginosa at different mass concentrations, wherein: Figure 7 (a) is the antibacterial effect test diagram of different mass concentrations of organic silicon carrier (Zn / oSiNP), Figure 7 (b) is the antibacterial effect test diagram of composite nanoparticles (Zn / oSiNP@Ag) with different mass concentrations. Figure 7 (c) is the antibacterial effect test diagram of AgNO3 aqueous solution with different mass concentrations. Each figure shows the OD 600 The relationship between the value and time. Figure 7 (b) and Figure 7 (c) It can be seen that the minimum inhibitory concentrations MIC(Zn / oSiNP@Ag) and MIC(AgNO3) of the composite nanoparticles (Zn / oSiNP@Ag) and AgNO3 against Pseudomonas aeruginosa are 100μg / mL and 6μg / mL, respectively. Figure 7 (a) and Figure 7 (b) shows that the antibacterial effect of the organic silicon carrier (Zn / oSiNP) is relatively better than that of Ag + can be ignored, therefore, according to the formula MIC(Ag)=MIC(antibacterial agent)×L(Ag), it can be obtained that the minimum inhibitory concentration MIC of Ag in the composite nano-microspheres (Zn / oSiNP@Ag) and AgNO3 against Pseudomonas aeruginosa are 1.86μg / mL and 3.81μg / mL, respectively. Therefore, the inhibition rate of the composite nano-microspheres (Zn / oSiNP@Ag) against Pseudomonas aeruginosa is 2.05 times that of AgNO3.
[0089] 2.3. Sterilization rate test after a certain period of cultivation
[0090] After culturing in LB medium for 24 h, the OD 600 The bacterial solution with basically unchanged value was transferred to solid culture medium and cultured for 24 hours to characterize the minimum bactericidal concentration (MBC) against Pseudomonas aeruginosa. The results are as follows Figure 8-9 As shown, Figure 8 The graph is a test chart of bacterial growth of Pseudomonas aeruginosa cultured on agar plates with different mass concentrations of composite nanoparticles (Zn / oSiNP@Ag) for 24 hours. Figure 8 a~8f are the effect diagrams at 0μg / mL, 100μg / mL, 200μg / mL, 300μg / mL, 400μg / mL, and 600μg / mL, respectively; Fig. 9 The graph is a test chart of bacterial growth of Pseudomonas aeruginosa cultured on agar plates for 24 hours with different mass concentrations of AgNO3, where: Fig. 9 a~9f are the effect diagrams at 0μg / mL, 6μg / mL, 10μg / mL, 15μg / mL, 20μg / mL, and 25μg / mL, respectively. It can be obtained that MBC (Zn / oSiNP@Ag) and MBC (AgNO3) are 300μg / mL and 15μg / mL, respectively. Figure 7 (a) and Figure 7 (b) shows that the antibacterial effect of the organic silicon carrier (Zn / oSiNP) is relatively better than that of Ag + can be ignored, therefore, according to the formula MBC(Ag)=MBC(antibacterial agent)×L(Ag), it can be obtained that the minimum bactericidal concentration MBC of Ag in the composite nano-microspheres (Zn / oSiNP@Ag) and AgNO3 against Pseudomonas aeruginosa are 5.57μg / mL and 9.53μg / mL, respectively. Therefore, the bactericidal rate of the composite nano-microspheres (Zn / oSiNP@Ag) against Pseudomonas aeruginosa is 1.71 times that of AgNO3.
[0091] 3. Antibacterial test (Gram-positive bacteria - Bacillus subtilis)
[0092] 3.1. Antibacterial activity of different reagents
[0093] The organic silicon carrier (Zn / oSiNP), composite nanoparticles (Zn / oSiNP@Ag), solid SiO2 microspheres (by The method used TEOS (self-made, particle size 120nm) and mixed it evenly with LB medium, and the experimental process in 2.1 was followed, except that Pseudomonas aeruginosa was replaced by Bacillus subtilis. Fig.10 As shown, Fig.10 The figure shows the antibacterial test results of the organosilicon carrier (Zn / oSiNP), composite nanoparticles (Zn / oSiNP@Ag) and solid SiO2 microspheres against Bacillus subtilis in Example 1. It can be seen that compared with the solid SiO2 microsphere group, the organosilicon carrier (Zn / oSiNP) group has a certain antibacterial property, while the composite nanoparticles (Zn / oSiNP@Ag) have significant antibacterial property, which significantly improves the antibacterial effect.
[0094] 3.2 Comparison of antibacterial rates of different reagents
[0095] The test process in 3.2 was followed except that Pseudomonas aeruginosa was replaced by Bacillus subtilis. Fig.11 As shown, Fig.11 The figure is a test diagram of the antibacterial effect of each reagent in Example 1 on Bacillus subtilis at different mass concentrations, wherein: Fig.11 (a) is the antibacterial effect test diagram of organic silicon carrier (Zn / oSiNP) with different mass concentrations. Fig.11 (b) is the antibacterial effect test diagram of composite nanoparticles (Zn / oSiNP@Ag) with different mass concentrations. Fig.11 (c) is the antibacterial effect test diagram of AgNO3 aqueous solution with different mass concentrations. Fig.11 (b) and Fig.11 (c) It can be seen that the minimum inhibitory concentrations MIC(Zn / oSiNP@Ag) and MIC(AgNO3) of the composite nanoparticles (Zn / oSiNP@Ag) and AgNO3 against Bacillus subtilis are 300μg / mL and 10μg / mL, respectively. Fig.11 (a) and Fig.11 (b) shows that the antibacterial effect of the organic silicon carrier (Zn / oSiNP) is relatively better than that of Ag + can be ignored, therefore, according to the formula MIC(Ag)=MIC(antibacterial agent)×L(Ag), it can be obtained that the minimum inhibitory concentration MIC of Ag in the composite nano-microspheres (Zn / oSiNP@Ag) and AgNO3 against Bacillus subtilis are 5.57μg / mL and 6.35μg / mL, respectively. Therefore, the inhibition rate of the composite nano-microspheres (Zn / oSiNP@Ag) against Bacillus subtilis is 1.14 times that of AgNO3.
[0096] 3.3. Sterilization rate test after a certain period of cultivation
[0097] The test process in 2.3 was followed, except that Pseudomonas aeruginosa was replaced by Bacillus subtilis, and the minimum bactericidal concentration (MBC) against Bacillus subtilis was characterized. The results are shown in Figure 12-13 As shown, Fig.12 The graph is a test chart of bacterial growth of Bacillus subtilis cultured with different mass concentrations of composite nanoparticles (Zn / oSiNP@Ag) on agar plates for 24 hours. Fig.12 a~12d are the effect diagrams at 0μg / mL, 300μg / mL, 400μg / mL, and 600μg / mL respectively; Fig.13 The figure is a test chart of bacterial growth of Bacillus subtilis culture solution with different mass concentrations of AgNO3 cultured on agar plate for 24 hours, among which, Fig.13 a~13e are the effect diagrams at 0μg / mL, 10μg / mL, 15μg / mL, 20μg / mL, and 25μg / mL, respectively. It can be obtained that MBC (Zn / oSiNP@Ag) and MBC (AgNO3) are 400μg / mL and 20μg / mL, respectively. Fig.11 (a) and Fig.11(b) shows that the antibacterial effect of the organic silicon carrier (Zn / oSiNP) is relatively better than that of Ag + can be ignored, therefore, according to the formula MBC(Ag)=MBC(antibacterial agent)×L(Ag), it can be obtained that the minimum bactericidal concentration MBC of Ag in the composite nano-microspheres (Zn / oSiNP@Ag) and AgNO3 against Bacillus subtilis are 7.42μg / mL and 12.7μg / mL, respectively. Therefore, the bactericidal rate of the composite nano-microspheres (Zn / oSiNP@Ag) against Bacillus subtilis is 1.71 times that of AgNO3.
[0098] Example 2
[0099] 1. Preparation of antimicrobial microspheres
[0100] 1.1. Preparation of Zn / oSiNP microsphere carrier
[0101] a) The method was carried out in accordance with Example 1, except that the amount of 3-aminopropyltriethoxysilane was increased and the amount of water was adjusted so that the molar ratio of zinc nitrate hexahydrate to 3-aminopropyltriethoxysilane was 1:15 and the volume ratio of 3-aminopropyltriethoxysilane to water was 1:30. The morphology of the obtained microspheres is as follows: Fig.14 As shown, the particle size is 120-200 nm.
[0102] b) The method was carried out in accordance with Example 1, except that the irradiation conditions were: dose rate 50 Gy / min, irradiation time 24 h, and total absorbed dose 72 kGy.
[0103] 1.2 Preparation of Zn / oSiNP@Ag microspheres
[0104] c) The method was carried out in accordance with Example 1, except that the amount of the AgNO3 aqueous solution was changed to a concentration of 0.08 mol / L, a total of 5 mL, i.e., the molar ratio of AgNO3: 3-aminopropyltriethoxysilane in step a) was 0.5:1; at the same time, the magnetic stirring time was changed to 4 h.
[0105] d) The method was carried out in accordance with Example 1, except that the amount of the NaBH4 aqueous solution was changed, specifically to a concentration of 0.16 mol / L, a total of 5 mL, that is, the molar ratio of NaBH4:AgNO3 in the AgNO3 aqueous solution in step c) was 2:1.
[0106] The morphology of the obtained Zn / oSiNP@Ag microspheres is shown in Fig.15 As shown, the particle size is 120-200 nm, the size of the silver nanoparticles loaded thereon is 10-15 nm, and the loading rate L(Ag)=2.06%.
[0107] 2. Antibacterial test (Gram-negative bacteria - Pseudomonas aeruginosa)
[0108] The test was carried out according to the experimental process of 2.2 in Example 1. The results showed that the minimum inhibitory concentration MIC of Ag in the composite nano-microspheres (Zn / oSiNP@Ag) against Pseudomonas aeruginosa was 2.06 μg / mL. Therefore, the inhibition rate of the composite nano-microspheres (Zn / oSiNP@Ag) against Pseudomonas aeruginosa was 1.85 times that of AgNO3 (MIC=3.81 μg / mL).
[0109] The test was carried out according to the experimental process of 2.3 in Example 1. The results showed that the minimum bactericidal concentration MBC of Ag in the composite nano-microspheres (Zn / oSiNP@Ag) against Pseudomonas aeruginosa was 6.18 μg / mL. Therefore, the bactericidal rate of the composite nano-microspheres (Zn / oSiNP@Ag) against Pseudomonas aeruginosa was 1.54 times that of AgNO3 (MBC=9.53 μg / mL).
[0110] 3. Antibacterial test (Gram-positive bacteria - Bacillus subtilis)
[0111] The test was carried out according to the experimental process of 3.2 in Example 1. The results showed that the minimum inhibitory concentration MIC of Ag in the composite nano-microspheres (Zn / oSiNP@Ag) against Bacillus subtilis was 6.18 μg / mL. Therefore, the antibacterial rate of the composite nano-microspheres (Zn / oSiNP@Ag) against Bacillus subtilis was 1.03 times that of AgNO3 (MIC=6.35 μg / mL).
[0112] The test was carried out according to the experimental process of 3.3 in Example 1. The results showed that the minimum bactericidal concentration MBC of Ag in the composite nano-microspheres (Zn / oSiNP@Ag) against Bacillus subtilis was 8.24 μg / mL. Therefore, the bactericidal rate of the composite nano-microspheres (Zn / oSiNP@Ag) against Bacillus subtilis was 1.54 times that of AgNO3 (MBC=12.7 μg / mL).
[0113] Specific examples are used herein to illustrate the principles and implementation methods of the present invention. The description of the above embodiments is only used to help understand the method of the present invention and its core ideas, including the best mode, and also enable any technician in the field to practice the present invention, including making and using any device or system, and implementing any combined method. It should be pointed out that for ordinary technicians in this technical field, without departing from the principle of the present invention, the present invention can also be improved and modified, and these improvements and modifications also fall within the scope of protection of the claims of the present invention. The scope of patent protection of the present invention is defined by the claims and may include other embodiments that can be thought of by those skilled in the art. If these other embodiments have structural elements similar to the literal expression of the claims, or if they include equivalent structural elements that are not substantially different from the literal expression of the claims, then these other embodiments should also be included in the scope of the claims.
Claims
1. A method for preparing a metal-organic silicon composite nano antibacterial agent, It is characterized in that The following steps are involved: a) mixing zinc nitrate hexahydrate, 3-aminopropyltriethoxysilane and water to obtain a mixed solution; b) Under a protective atmosphere, the mixed solution is subjected to 60 Coγ-ray irradiation, then solid-liquid separation and washing, the obtained solid product is dispersed in water to obtain a zinc-organosilicon nanoparticle dispersion; c) mixing the zinc-organic silicon nanosphere dispersion with AgNO 3 The aqueous solution is mixed, and then solid-liquid separation and washing are performed, and the obtained solid product is dispersed in water to obtain a dispersion; d) mixing the dispersion obtained in step c) with a reducing agent solution for reaction, and then performing solid-liquid separation, washing and drying to obtain a metal-organosilicon composite nano antibacterial agent; In step a), the molar ratio of zinc nitrate hexahydrate to 3-aminopropyltriethoxysilane is 1:(9-15); Step c) AgNO 3 AgNO in aqueous solution 3 : The molar ratio of 3-aminopropyltriethoxysilane in step a) is (0.05-0.5):1; In step d), the reducing agent solution is NaBH 4 Aqueous solution; In step d), the reducing agent in the reducing agent solution is: AgNO in step c). 3 AgNO in aqueous solution 3 The molar ratio is (2-5):1; In step b), the irradiation conditions are: dose rate 9-76 Gy / min, irradiation time 2-24 h, and total absorbed dose 1-110 kGy.
2. The preparation method according to claim 1, It is characterized in that In step a), the volume ratio of 3-aminopropyltriethoxysilane to water is 1:(25-50).
3. The preparation method according to claim 1, It is characterized in that In step d), the drying is freeze-drying.
4. A metal-organic silicon composite nano antibacterial agent prepared by the preparation method according to any one of claims 1 to 3.
5. Use of the metal-organic silicon composite nano antibacterial agent according to claim 4 as an antibacterial agent for Gram-positive bacteria and / or Gram-negative bacteria.
